This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Juno Therapeutics Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kien Khuu-duong: Innovator in Cell Therapy
Introduction: Kien Khuu-duong is an inventor based in Seattle, WA, who is currently associated with Juno Therapeutics GmbH. He has made significant contributions to the field of cell therapy, focusing on innovative methods for culturing and engineering immune cells. Although he does not hold any granted patents, his work is paving the way for advancements in therapeutic applications.
Latest Patent Applications: Kien Khuu-duong has filed several notable patent applications. One of his latest applications is titled "Serum-Free Media Formulation for Culturing Cells and Methods of Use Thereof." This application provides a serum-free media for culturing immune cells, including genetically engineered cells. It also includes methods for producing serum-free media and culturing cells in its presence. Another significant application is "Process for Producing a Composition of Engineered T Cells." This disclosure outlines methods for genetically engineering T cells, such as CD4+ and CD8+ T cells, for use in cell therapy. The methods described aim to produce genetically engineered T cells efficiently and reliably.
Conclusion: Kien Khuu-duong is an emerging inventor in the field of cell therapy, contributing valuable research and innovative applications that may lead to significant advancements in medical treatments. His work at Juno Therapeutics GmbH highlights the importance of developing new methodologies for cell engineering and cultivation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile